Pilot study of mutant ras peptide-based vaccine as an adjuvant treatment in pancreatic and colorectal cancers
作者:
Toubaji,A. [1]
;
Achtar,M. [2]
;
Provenzano,M. [3]
;
Herrin,V.E. [4]
;
Behrens,R. [5]
;
Hamilton,M. [6]
;
Bernstein,S. [7]
;
Venzon,D. ;
Gause,B. ;
Marincola,F. ;
Khleif,S.N.
作者单位:
Medical Oncology Clinical Research Unit (MOCRU), NNMC, Bethesda, MD, United States
[1]
Immunogenetic Section, DTM, NIH, Bethesda, MD, United States, Oncology and Tissue Engineering
[2]
Department of Hematology/Oncology, National Naval Medical Center, Bethesda, MD, United States
[3]
Cancer Vaccine Section, Vaccine Branch, NIH, 8901 Wisconsin Ave, Bethesda, MD 20889, United States
[4]
Medical Oncology Clinical Research Unit (MOCRU), NNMC, Bethesda, MD, United States, Avalon
[5]
Immunogenetic Section, DTM, NIH, Bethesda, MD, United States
[6]
Biostatistics and Data Management Section, CCR, NIH, Bethesda, MD, United States
[7]
期刊:
发布时间:
2013-11-21
- 翻译满意度评价:
- 提交
- 浏览:0
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文